Cargando…
Teprotumumab for the treatment of mild compressive optic neuropathy in thyroid eye disease: A report of two cases
PURPOSE: To report two cases of thyroid eye disease (TED) associated compressive optic neuropathy (CON) that resolved after treatment with teprotumumab. OBSERVATION: Two patients presented with active TED resulting in mild CON with the typical corresponding visual field (VF) defects. Both patients w...
Autores principales: | Chiou, Carolina A., Reshef, Edith R., Freitag, Suzanne K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050009/ https://www.ncbi.nlm.nih.gov/pubmed/33889787 http://dx.doi.org/10.1016/j.ajoc.2021.101075 |
Ejemplares similares
-
Teprotumumab for the treatment of chronic thyroid eye disease
por: Ugradar, Shoaib, et al.
Publicado: (2021) -
Efficacy and Safety of Teprotumumab in Thyroid Eye Disease
por: Teo, Honeylen Maryl, et al.
Publicado: (2021) -
Teprotumumab in advanced reactivated thyroid eye disease
por: Cheng, Olivia T., et al.
Publicado: (2022) -
Improvement of asymmetric thyroid eye disease with teprotumumab
por: Ugradar, Shoaib, et al.
Publicado: (2022) -
Teprotumumab: A Review in Thyroid Eye Disease
por: Nie, Tina, et al.
Publicado: (2022)